0001345281-20-000007.txt : 20201120
0001345281-20-000007.hdr.sgml : 20201120
20201120171323
ACCESSION NUMBER: 0001345281-20-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201104
FILED AS OF DATE: 20201120
DATE AS OF CHANGE: 20201120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAY E GERALD
CENTRAL INDEX KEY: 0001053310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31668
FILM NUMBER: 201333384
MAIL ADDRESS:
STREET 1: C/O 225 LONG AVENUE
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC
CENTRAL INDEX KEY: 0001016504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222407475
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
BUSINESS PHONE: 9739260816
MAIL ADDRESS:
STREET 1: 225 LONG AVENUE
STREET 2: BUILDING 15
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC
DATE OF NAME CHANGE: 20020912
FORMER COMPANY:
FORMER CONFORMED NAME: CHEM INTERNATIONAL INC
DATE OF NAME CHANGE: 19960716
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-11-04
0
0001016504
INTEGRATED BIOPHARMA INC
inbp
0001053310
KAY E GERALD
C/O 225 LONG AVENUE
HILLSIDE
NJ
07205
1
1
1
0
Executive Chairman & President
Stock Option (right to buy)
0.72
2020-11-04
4
A
0
100000
0
A
2025-11-04
Common Stock
100000
100000
D
The option vests in three equal annual installments beginning on November 4, 2021.
/s/ E. Gerald Kay
2020-11-20